RP Cure Tracker

Trials / NCT02617966

Rod and Cone Mediated Function in Retinal Disease

Recruiting now Observational Natural history / observational

Sponsor
National Eye Institute (NEI)
Treatment
Not listed
Gene
Not stated
Conditions
Retinal Degeneration, Retinitis Pigmentosa, Stargardt's Disease
Ages
5 Years to 100 Years
Enrollment
500 participants
Started
2016-03-24
Main results expected
2029-12-30
Results posted
Not yet
Record last updated
2026-11-09

What the study is testing

Background:

Retinal diseases cause the loss of rod and cone photoreceptors. Symptoms include vision loss and night blindness. Researchers want to learn about rod and cone function in healthy people and people with retinal disease. They want to know if how well a person sees in the dark can test the severity of retinal disease.

Objectives:

To find out if how well a person sees in the dark can test the severity of retinal disease. To find out if this can help detect retinal disease and track its changes.

Eligibility:

People ages 5 and older with:

Retinal disease OR

20/20 vision or better with or without correction in at least one eye

Design:

Participants will be screened with medical and eye history and eye exam. Those with retinal disease will also have:

Eye imaging: Drops dilate the eye and pictures are taken of it.

Visual field testing: Participants look into a bowl and press a button when they see light.

Electroretinogram (ERG): An electrode is taped to the forehead. Participants sit in the

dark with their eyes patched for 30 minutes. Then they get numbing drops and contact

lenses. Participants watch lights while retina signals are recorded.

Visit 1 will be 3-8 hours. Participants will have up to 6 more visits over 6-12 months. Visits include:

Eye exam and imaging

Time course of dark adaptation: Participants view a background light for 5 minutes then

push a button when they see colored light.

Dark adapted sensitivity: Participants sit in the dark for 45 minutes. They push a button when

they see colored light.

For participants with retinal disease, ERG and visual field testing

...

Where it runs

United States (1)

Open on ClinicalTrials.gov for contacts and eligibility